ZyVersa Therapeutics’ CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 2nd Annual Kidney Conference to be Held Virtually on July 25, 2023

<p>ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of multiple CNS and other inflammatory diseases Mr. Glover will provide an update on the development status of Cholesterol […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/zyversa-therapeutics-ceo-stephen-c-glover-is-an-invited-speaker-at-h-c-wainwright-2nd-annual-kidney-conference-to-be-held-virtually-on-july-25-2023/">ZyVersa Therapeutics’ CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 2nd Annual Kidney Conference to be Held Virtually on July 25, 2023</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>